Cart
sales@molnova.com
4-Chloro-2-bromoacetophenone
CAS No. 536-38-9
4-Chloro-2-bromoacetophenone( —— )
Catalog No. M24520 CAS No. 536-38-9
4-Chloro-2'-bromoacetophenone against glycogen synthase kinase-3 (GSK-3beta).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | 241 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Chloro-2-bromoacetophenone
-
NoteResearch use only, not for human use.
-
Brief Description4-Chloro-2'-bromoacetophenone against glycogen synthase kinase-3 (GSK-3beta).
-
Description4-Chloro-2'-bromoacetophenone against glycogen synthase kinase-3 (GSK-3beta).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number536-38-9
-
Formula Weight233.49
-
Molecular FormulaC8H6BrClO
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1=CC(=CC=C1C(=O)CBr)Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CCG 203769
CCG 203769 is a selective inhibitor of RGS4 with an IC50 of 17 nM for the RGS4-Gαo protein-protein interaction.
-
GSK-3 inhibitor 4
GSK-3 inhibitor 4 is an orally active and brain-permeable compound that acts as a triple inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM (CDK2), and 0.68 μM (CDK5).
-
AZD1080
AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively.
